96 related articles for article (PubMed ID: 19194204)
1. Long-term disease control of refractory anaplastic large cell lymphoma with vinblastine.
Garner R; Li Y; Gray B; Zori R; Braylan R; Wall J; Hunger SP
J Pediatr Hematol Oncol; 2009 Feb; 31(2):145-7. PubMed ID: 19194204
[TBL] [Abstract][Full Text] [Related]
2. Single-drug vinblastine as salvage treatment for refractory or relapsed anaplastic large-cell lymphoma: a report from the French Society of Pediatric Oncology.
Brugières L; Pacquement H; Le Deley MC; Leverger G; Lutz P; Paillard C; Baruchel A; Frappaz D; Nelken B; Lamant L; Patte C
J Clin Oncol; 2009 Oct; 27(30):5056-61. PubMed ID: 19738127
[TBL] [Abstract][Full Text] [Related]
3. Long-term remission of children with relapsed and secondary anaplastic large cell non-Hodgkin lymphoma (ALCL) following treatment with pulsed dexamethasone and low dose etoposide.
Stockklausner C; Behnisch W; Mechtersheimer G; Möller P; Kulozik AE
Pediatr Blood Cancer; 2008 Jan; 50(1):126-9. PubMed ID: 16609950
[TBL] [Abstract][Full Text] [Related]
4. Relapsed or refractory anaplastic large-cell lymphoma in children and adolescents after Berlin-Frankfurt-Muenster (BFM)-type first-line therapy: a BFM-group study.
Woessmann W; Zimmermann M; Lenhard M; Burkhardt B; Rossig C; Kremens B; Lang P; Attarbaschi A; Mann G; Oschlies I; Klapper W; Reiter A
J Clin Oncol; 2011 Aug; 29(22):3065-71. PubMed ID: 21709186
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment with daclizumab of refractory anaplastic lymphoma.
Costa V; Oliva T; Norton L
Pediatr Blood Cancer; 2009 Dec; 53(6):1130-1. PubMed ID: 19598219
[TBL] [Abstract][Full Text] [Related]
6. Long-term survival of a child with refractory anaplastic large cell lymphoma following therapy with an antisense oligonucleotide, topotecan, and vinblastine.
Wrobel G; Chaber R; Rygier J; Bonar J; Muszynska-Roslan K; Chybicka A
Hematol Oncol; 2015 Mar; 33(1):52-5. PubMed ID: 21809366
[TBL] [Abstract][Full Text] [Related]
7. Vinblastine in children and adolescents with high-risk anaplastic large-cell lymphoma: results of the randomized ALCL99-vinblastine trial.
Le Deley MC; Rosolen A; Williams DM; Horibe K; Wrobel G; Attarbaschi A; Zsiros J; Uyttebroeck A; Marky IM; Lamant L; Woessmann W; Pillon M; Hobson R; Mauguen A; Reiter A; Brugières L
J Clin Oncol; 2010 Sep; 28(25):3987-93. PubMed ID: 20679620
[TBL] [Abstract][Full Text] [Related]
8. Allogeneic haematopoietic stem cell transplantation in relapsed or refractory anaplastic large cell lymphoma of children and adolescents--a Berlin-Frankfurt-Münster group report.
Woessmann W; Peters C; Lenhard M; Burkhardt B; Sykora KW; Dilloo D; Kremens B; Lang P; Führer M; Kühne T; Parwaresch R; Ebell W; Reiter A
Br J Haematol; 2006 Apr; 133(2):176-82. PubMed ID: 16611309
[TBL] [Abstract][Full Text] [Related]
9. [Efficacy of therapy of different variants of anaplastic large T-cell lymphomas].
Vinogradova IuE; Lutsenko IN; Kaplanskaia IB; Vorob'ev IA; Samoĭlova RS; Gorgidze LA; Ryzhikova NA; Valiev TT; Giliazitdinova EA; Dzhulakian UL; Egorova EK; Zvonkov EE; Krasil'nikova BB; Magomedova AU; Margolin OV; Mar'in DS; Kremenetskaia AM; Kravchenko SK; Vorob'ev AI
Ter Arkh; 2008; 80(7):33-7. PubMed ID: 18763592
[TBL] [Abstract][Full Text] [Related]
10. Primary cutaneous anaplastic large cell lymphoma.
Daar G; Küpeli S; Yalçin B; Kesik V; Orhan D; Büyükpamukçu M
Pediatr Hematol Oncol; 2010 Oct; 27(7):558-63. PubMed ID: 20624005
[TBL] [Abstract][Full Text] [Related]
11. Management of multifocal primary cutaneous CD30 anaplastic large cell lymphoma.
Shehan JM; Kalaaji AN; Markovic SN; Ahmed I
J Am Acad Dermatol; 2004 Jul; 51(1):103-10. PubMed ID: 15243534
[TBL] [Abstract][Full Text] [Related]
12. Secondary ALK negative anaplastic large cell lymphoma in a patient with lymphomatoid papulosis of 40 years duration.
Marschalkó M; Eros N; Holló P; Hársing J; Bottlik G; Bátai A; Csukly Z; Masszi T; Szentirmai Z; Fodor J; Kárpáti S; Matolcsy A; Csomor J
Am J Dermatopathol; 2010 Oct; 32(7):708-12. PubMed ID: 20644462
[TBL] [Abstract][Full Text] [Related]
13. Primary cutaneous CD30-positive anaplastic large cell lymphoma in childhood: report of 4 cases and review of the literature.
Kumar S; Pittaluga S; Raffeld M; Guerrera M; Seibel NL; Jaffe ES
Pediatr Dev Pathol; 2005; 8(1):52-60. PubMed ID: 15719203
[TBL] [Abstract][Full Text] [Related]
14. Successful treatment of relapsed anaplastic large cell lymphoma with vinblastine monotherapy and allo-HSCT with reduced intensity conditioning regimen.
Miyagaki S; Imamura T; Okumura Y; Ito I; Fujiki A; Osone S; Ishida H; Hosoi H
Pediatr Int; 2015 Aug; 57(4):791-4. PubMed ID: 25847601
[TBL] [Abstract][Full Text] [Related]
15. [ATIC-ALK-positive anaplastic large cell lymphoma: a case report and review of the literature].
Matsubara K; Tanaka T; Taki T; Nakagawa A; Nigami H; Tamura A; Fukaya T
Rinsho Ketsueki; 2008 May; 49(5):325-30. PubMed ID: 18572809
[TBL] [Abstract][Full Text] [Related]
16. Recurrent childhood anaplastic large cell lymphoma: a retrospective analysis of registered cases in Japan.
Mori T; Takimoto T; Katano N; Kikuchi A; Tabuchi K; Kobayashi R; Ayukawa H; Kumagai MA; Horibe K; Tsurusawa M
Br J Haematol; 2006 Mar; 132(5):594-7. PubMed ID: 16445832
[TBL] [Abstract][Full Text] [Related]
17. Primary CD30/ALK-1 positive anaplastic large cell lymphoma of the skeletal muscle in a child.
Driss M; Abbes I; Mrad K; Sassi S; Oubich F; Barsaoui S; Romdhane KB
Pathologica; 2009 Apr; 101(2):97-100. PubMed ID: 19886557
[TBL] [Abstract][Full Text] [Related]
18. [Efficacy of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin's lymphoma].
Huang HQ; Bu Q; Xia ZJ; Lin XB; Wang FH; Li YH; Peng YL; Pan ZH; Wang SS; Lin TY; Jiang WQ; Guan ZZ
Ai Zheng; 2006 Apr; 25(4):486-9. PubMed ID: 16613686
[TBL] [Abstract][Full Text] [Related]
19. Localized perineal cutaneous nodules: a case of recurrent systemic anaplastic large-cell lymphoma.
Hernandez C; Puangsuvan SN; Peterson A; Robinson JK
Clin Exp Dermatol; 2009 Dec; 34(8):e722-5. PubMed ID: 20055841
[TBL] [Abstract][Full Text] [Related]
20. Brentuximab vedotin (SGN-35) in a 3-year-old child with relapsed systemic anaplastic large cell lymphoma.
Mikles B; Levine J; Gindin T; Bhagat G; Satwani P
J Pediatr Hematol Oncol; 2014 Mar; 36(2):e85-7. PubMed ID: 23588340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
